Response-adaptive designs are used in phase III clinical trials to allocate a larger number of patients to the better treatment arm. Optimal designs are explored in the recent years in the context of response-adaptive designs, in the frequentist view point only. In the present paper, we propose some response-adaptive designs for two treatments based on Bayesian prediction for phase III clinical trials. Some properties are studied and numerically compared with some existing competitors. A real data set is used to illustrate the applicability of the proposed methodology where we redesign the experiment using parameters derived from the data set.
WeiLJDurhamS. The randomized play-the-winner rule in medical trials. J Am Stat Assoc1978; 73: 840–843.
2.
AthreyaKBKarlinS. Embedding of urn schemes into continuous time Markov branching processes and related limit theorems. Ann Math Stat1968; 39: 1801–1817.
3.
WeiLJ. The generalized Pólya’s urn for sequential medical trials. Ann Stat1979; 7: 291–296.
4.
DurhamSDYuCF. Randomized play-the-leader rules for sequential sampling from two populations. Prob Eng Inform Sci1990; 4: 355–367.
5.
Li W, Durham SD and Flournoy N. Randomized Pólya urn designs. In: Proceedings of the biometric section of the American Statistical Association, 1996, pp. 166–170. Washington, DC: American Statistical Association.
6.
IvanovaARosenbergerWFDurhamSDet al.A birth and death urn for randomized clinical trials. Sankhya B2000; 62: 104–118.
7.
IvanovaA. A play-the-winner-type urn design with reduced variability. Metrika2003; 58: 1–13.
RosenbergerWFLachinJL. Randomization in clinical trials: theory and practice, New York: Wiley, 2002.
11.
BiswasABhattacharyaRZhangL. Optimal response-adaptive designs for continuous responses in phase III trials. Biometric J2007; 49: 928–940.
12.
ChengYShenY. Bayesian adaptive designs for clinical trials. Biometrika2005; 92: 633–646.
13.
ZhouXLiuSKimESet al.Bayesian adaptive design for targeted therapy development in lung cancer a step toward personalized medicine. Clin Trial2008; 5: 181193–181193.
14.
BiswasAAngersJ-F. A Bayesian adaptive design in clinical trials for continuous responses. Stat Neerl2002; 56: 400–414.
SiegmundD. Sequential analysis: tests and confidence intervals, Springer: Heidelberg, 1985.
22.
BartlettRHRoloffDWCornellRGet al.Extracorporeal circulation in neonatal respiratory failure: a prospective randomized trial. Pediatrics1985; 76: 479–487.
23.
TamuraRFariesDAndersenJet al.A case study of an adaptive clinical trial in the treatment of out-patients with depressive disorder. J Am Stat Assoc1994; 89: 768–776.
24.
WareJH. Investigating therapies of potentially great benefit: ECMO. Stat Sci1989; 4: 298–340.
25.
FushimiM. An improved version of a Sobel-Weiss play-the-winner procedure for selecting the better of two binomial populations. Biometrika1973; 60: 517–523.
26.
KieferJEWeissGH. Truncated version of a play-the-winner rule for choosing the better of two binomial populations. J Am Stat Assoc1974; 69: 807–809.
27.
SobelMWeissGH. Play-the-winner rule and inverse sampling in selecting the better of two binomial populations. J Am Stat Assoc1971; 66: 545–551.
28.
HoelDG. An inverse stopping rule for play-the-winner sampling. J Am Stat Assoc1972; 67: 148–151.
29.
BandyopadhyayUBiswasA. Some sequential tests in clinical trials based on randomized play-the-winner rule. Calcutta Stat Assoc Bull1997; 47: 67–89.
30.
BandyopadhyayUBiswasA. Sequential comparison of two treatments in clinical trials: a decision theoretic approach based on randomized play-the-winner rule. Sequent Anal1997; 16: 65–92.
31.
BandyopadhyayUBiswasA. Some sequential-type conditional tests in clinical trials based on generalized randomized play-the-winner rule. Metron2000; LVIII: 187–200.
32.
BandyopadhyayUBiswasA. Test of Bernoulli success probability in inverse sampling for nearer alternatives using adaptive allocation. Stat Neerl2002; 56: 387–399.
33.
BandyopadhyayUBiswasA. Nonparametric group sequential designs in randomized clinical trials. Aust New Zeal J Stat2003; 45: 367–376.
34.
Baldi AntogniniAGiovalnoliA. On the large sample optimality of sequential designs for comparing two or more treatments. Sequent Anal2005; 24: 205–217.
35.
Baldi AntogniniAGiovagnoliA. Inference for sequential experiments with an adaptive treatment allocation and/or an adaptive stopping rule. Metron2006; LXIV: 29–45.
36.
ZhuHHuF. Sequential monitoring of response-adaptive randomized clinical trials. Ann Stat2010; 38: 2218–2241.
37.
JennisonCTurnbullBW. Group Sequential Methods with Applications to Clinical Trials, Boca Raton, FL: Chapman and Hall/CRC Press, 2000.
38.
StallardNRosenbergerWF. Exact group-sequential designs for clinical trials with randomized play-the-winner allocation. Stat Med2002; 21: 467–480.
39.
WhiteheadJ. Stopping clinical trials by design. Nat Rev Drug Discov2004; 3: 973–977.
ConnorEMSperlingRSGelberRet al.Reduction of maternal-infant transmission of human immunodeficiency virus of type 1 with zidovudine treatment. N Engl J Med1994; 331: 1173–1180. Report written for the Pediatrics AIDS Clinical Trial Group Protocol 076 Study Group.
42.
YaoQWeiLJ. Play the winner for phase II/III clinical trials. Stat Med1996; 15: 2413–2423.
